The Allen Institute is launching a $400 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer’s, Parkinson’s, Huntington’s, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has made treating disease its goal. Read More
